Citigroup’s RESPONSE GENETICS, INC COMMON SHS (DELAWARE) RGDX Stock Holding History

Citigroup’s Portfolio RGDX Stock Details RGDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-53	Closed	–	–	8268
2015 Q2	$0	Buy	+53	New	+$18	﹤0.01%	8054
2015 Q1	–	Sell	-70	Closed	–	–	7702
2014 Q4	$0	Buy	+70	New	+$39	﹤0.01%	7549
2014 Q3	–	Sell	-272	Closed	–	–	7536
2014 Q2	$0	Sell	272 -778	-74%	-$814	﹤0.01%	7536
2014 Q1	$1K	Sell	1,050 -2,428	-70%	-$3.39K	﹤0.01%	6938
2013 Q4	$4K	Buy	3,478 +2,931	+536%	+$4.8K	﹤0.01%	6693
2013 Q3	$1K	Sell	547 -1,282	-70%	-$2.59K	﹤0.01%	6745
2013 Q2	$2K	Buy	+1,829	New	+$2.49K	﹤0.01%	6572

Citigroup's RGDX Position: Q3 2015 in Review

Citigroup sold out of RESPONSE GENETICS, INC COMMON SHS (DELAWARE) (RGDX) in Q3 2015, closing a stake of 53 shares.

Citigroup first reported a position in RGDX in Q2 2013 and held it in 7 quarters. The position peaked at $4K in Q4 2013. 1 fund tracked by Wall St. Rank holds RGDX as of Q3 2015.

Citigroup reported no remaining RESPONSE GENETICS, INC COMMON SHS (DELAWARE) position as of Q3 2015 after selling out during the quarter.
Citigroup sold 53 RESPONSE GENETICS, INC COMMON SHS (DELAWARE) shares in Q3 2015.
Citigroup first reported a position in RESPONSE GENETICS, INC COMMON SHS (DELAWARE) in Q2 2013 and held it in 7 quarters.
Citigroup's RESPONSE GENETICS, INC COMMON SHS (DELAWARE) position peaked at $4K in Q4 2013.
1 fund tracked by Wall St. Rank held RESPONSE GENETICS, INC COMMON SHS (DELAWARE) as of Q3 2015.

Based on Citigroup's 13F filing for Q3 2015, filed 13 Nov 2015.